NEW YORK, April 4 - A broad restructuring undertaken at Monsanto today has put a question mark over the future of its many collaborations with genomics and bioinformatics tools and technology companies.

Monsanto said today that its restructuring, which will cost as much as $124 million, would slash about 5 percent of its staff around the world, or between 600 and 700 of its 14,600 employees.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.